PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
182 hedge funds and large institutions have $1.47B invested in Provention Bio, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 52 increasing their positions, 35 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
49% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 35
37% more funds holding
Funds holding: 133 → 182 (+49)
Holders
182
Holding in Top 10
9
Calls
$45.6M
Puts
$27.1M
Top Buyers
| 1 | +$75.6M | |
| 2 | +$70.5M | |
| 3 | +$35.8M | |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$32.9M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$27M |
Top Sellers
| 1 | -$145M | |
| 2 | -$15.8M | |
| 3 | -$11.9M | |
| 4 |
VA
VR Adviser
New York
|
-$11.8M |
| 5 |
Two Sigma Investments
New York
|
-$11.7M |